s6y

Alvotech

Ticker
ALVO, ALVOW
CIK
1898416
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Alvotech Lux Holdings S.A.S.

Ownership 10

  1. SC 13G/A Major Shareholders
  2. SC 13D/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D/A Major Shareholders
  7. SC 13D/A Major Shareholders
  8. SC 13D Major Shareholders
  9. SC 13D Major Shareholders
  10. SC 13G Major Shareholders

Prospectus 66

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  3. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. RW Registration Withdrawal Request
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 66 prospectus filings

Other 228

  1. SCHEDULE 13G
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 228 other filings